Simon N.R. Harford Amicus Therapeutics, Inc. (FOLD) insider trading activity

Simon N.R. Harford is Chief Financial Officer of AMICUS THERAPEUTICS, INC.. Currently has a direct ownership of 227,427 shares of FOLD, which is worth approximately $1.92 Million. The most recent transaction as insider was on Jan 03, 2025, when has been sold 83,073 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 227K

0% 3M change

38.37% 12M change

Total Value Held $1.92 Million

Simon N.R. Harford Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Date	Transaction	Value	Shares Traded	Shares Held	Form
Jan 03 2025	BUY Grant, award, or other acquisition	-	83,073 Added 26.75%	227,427 Common Stock
Jan 02 2025	SELL Payment of exercise price or tax liability	$69,657 $9.31 p/Share	7,482 Reduced 4.93%	144,354 Common Stock
Aug 21 2024	SELL Payment of exercise price or tax liability	$151,475 $12.09 p/Share	12,529 Reduced 7.62%	151,836 Common Stock
Jan 02 2024	BUY Grant, award, or other acquisition	-	57,392 Added 25.88%	164,365 Common Stock
Aug 21 2023	BUY Grant, award, or other acquisition	-	106,973 Added 50.0%	106,973 Common Stock

Also insider at

ALBO

ALBIREO PHARMA, INC. Healthcare

CFO and Treasurer

SNH

Simon N.R. Harford

Chief Financial Officer

Boston, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FOLD shares.

Notify only if

Value

Any

Insider Trading

Get notified when an Amicus Therapeutics, Inc. insider buys or sells FOLD shares.

Notify only if

Operation

Any

Value

Any

Type

P - Open market or private purchase×

S - Open market or private sale×

V - Transaction voluntarily reported earlier than required×

A - Grant, award, or other acquisition×

D - Sale (or disposition) back to the issuer×

F - Payment of exercise price or tax liability×

I - Discretionary transaction×

M - Exercise of conversion of derivative security×

C - Conversion of derivative security×

E - Expiration of short derivative position×

H - Expiration (or cancellation) of long derivative position with value received×

O - Exercise of out-of-the-money derivative securities×

X - Exercise of in-the-money or at-the-money derivatives securities×

G - Bona fide gift×

L - Small Acquisition×

W - Acquisition or disposition by will or laws×

Z - Deposit into or withdrawal from voting trust×

J - Other acquisition or disposition×

K - Transaction in equity swap or similar instrument×

U - Disposition due to a tender of shares in a change of control transaction×

20 item(s) selected

News

Receive news related to AMICUS THERAPEUTICS, INC.

Track Activities on FOLD

Account